The Latest Breaking News from 23andMe

23andMe (ME) saw its shares slump in price after it reported its fourth-quarter earnings results last month. However, given the company's multiple FDA authorizations for over-the-counter genetic health risk reports, would it be worth scooping up its shares now? Read on, let's find out.

Top long Covid symptoms reported by survey participants included brain fog, fatigue, and shortness of breath

Scientists believe Africa is where modern humans first emerged. For the past decade, our team of genetic researchers from the Henn Lab have worked among the Khoe-San and self-identified “Coloured” communities in South Africa, which comprise multiple ethnic groups in the region, requesting DNA and generating genetic data to help…

The COVID-19 pandemic has accelerated digital adoption in healthcare. And because this trend is attracting massive investments into digital health care, Wall Street analysts expect popular health tech stocks Exact Sciences Corp (EXAS), GoodRx Holdings (GDRX), 23andMe (ME) to rally in price soon. Read on.

The woman explained how her family had recently completed 23andMe DNA tests, which uncovered the major lie her gran had been spinning for years.

A woman has shared the shocking discovery she made about her family after taking a 23andMe DNA test which uncovered relatives she never knew existed and her grandmother's huge secret

23andMe Holding Co (NASDAQ: ME) has updated its FY22 guidance following the inclusion of telehealth operations into its consumer business. 

If you've ever wondered if there was more to your family's history, or maybe you're just curious to know who you are in more detail - if that's you, read on as we've rounded-up the top five ancestry DNA test kits to buy in 2022

Genetic testing company 23andMe Holding Co.